{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:49:27Z","timestamp":1782100167191,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog&amp;#x00ED;a","doi-asserted-by":"publisher","award":["264118"],"award-info":[{"award-number":["264118"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Notwithstanding evidence that tuberculosis (TB) is declining, one of the greatest concerns to public health is the emergence and spread of multi-drug resistant strains of <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MDR-TB). MDR-TB are defined as strains which are resistant to at least isoniazid (INH) and rifampicin, the two most potent TB drugs, and their increasing incidence is a serious concern. Recently, notable efforts have been spent on research to pursue novel treatments against MDR-TB, especially on synergistic drug combinations as they have the potential to improve TB treatment. Our research group has previously reported promising synergistic antimicrobial effects between transition-metal compounds and antibiotics in Gram-negative and Gram-positive bacteria. In this work, we evaluated antimycobacterial activity of transition-metals\/antibiotics combinatorial treatments against first-line drug resistant strains of <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. Our data showed that INH\/AgNO<jats:sub>3<\/jats:sub> combinatorial treatment had an additive effect (bactericidal activity) in an isoniazid-resistant clinical strain of <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. Moreover, <jats:italic>in vitro<\/jats:italic> evaluation of cytotoxicity induced by both, the individual tratments of AgNO<jats:sub>3<\/jats:sub> and INH and the combinatorial treatment of INH\/AgNO<jats:sub>3<\/jats:sub> in murine RAW 264.7 macrophages and human A549 lung cells; showed no toxic effects. Together, this data suggests that the INH\/AgNO<jats:sub>3<\/jats:sub> combinatorial treatment could be used in the development of new strategies to treat resistant strains of <jats:italic>Mycobacterium tuberculosis<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/s41598-019-42049-5","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T10:03:17Z","timestamp":1554199397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antibacterial Activity of combinatorial treatments composed of transition-metal\/antibiotics against Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"9","author":[{"given":"L. Z.","family":"Montelongo-Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-4639","authenticated-orcid":false,"given":"A.","family":"Le\u00f3n-Buitimea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-9941","authenticated-orcid":false,"given":"J. P.","family":"Palma-Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonzalez-Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Morones-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"42049_CR1","unstructured":"World Health Organization. Global tuberculosis report 2017. WHO\/HTM\/TB\/2017.23."},{"issue":"3","key":"42049_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1573398X113099990017","volume":"9","author":"DJ Sloan","year":"2013","unstructured":"Sloan, D. J., Davies, G. R. & Khoo, S. H. Recent advances in tuberculosis: New drugs and treatment regimens. Curr. Respir. Med. Rev. 9(3), 200\u2013210 (2013).","journal-title":"Curr. Respir. Med. Rev."},{"key":"42049_CR3","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1088\/0957-4484\/16\/10\/059","volume":"16","author":"JR Morones","year":"2005","unstructured":"Morones, J. R. et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 16, 2346\u20132353, https:\/\/doi.org\/10.1088\/0957-4484\/16\/10\/059 (2005).","journal-title":"Nanotechnology."},{"key":"42049_CR4","first-page":"69","volume":"10","author":"JR Morones-Ramirez","year":"2009","unstructured":"Morones-Ramirez, J. R. El uso de la Plata en los antibi\u00f3ticos del futuro. Revista Digital Universitaria. 10, 69\u201381 (2009).","journal-title":"Revista Digital Universitaria."},{"key":"42049_CR5","first-page":"56","volume":"36","author":"JRP Morones-Ramirez","year":"2010","unstructured":"Morones-Ramirez, J. R. P. metal precioso con amplio espectro de aplicaciones. Revista Ciencia y Desarrollo. 36, 56\u201362 (2010).","journal-title":"Revista Ciencia y Desarrollo."},{"key":"42049_CR6","first-page":"70","volume":"11","author":"JR Morones-Ramirez","year":"2010","unstructured":"Morones-Ramirez, J. R. Historia de la plata: Su impacto en las antiguas civilizaciones y la sociedad moderna. Revista Digital Universitaria. 11, 70\u201379 (2010).","journal-title":"Revista Digital Universitaria."},{"key":"42049_CR7","doi-asserted-by":"publisher","first-page":"190ra181","DOI":"10.1126\/scitranslmed.3006276","volume":"5","author":"JR Morones-Ramirez","year":"2013","unstructured":"Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S. & Collins, J. J. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl. Med. 5, 190ra181\u2013190ra181, https:\/\/doi.org\/10.1126\/scitranslmed.3006276 (2013).","journal-title":"Sci Transl. Med."},{"key":"42049_CR8","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/jac\/dkq294","volume":"65","author":"S Pal","year":"2010","unstructured":"Pal, S., Yoon, E. J., Park, S. H., Choi, E. C. & Song, J. M. Metallopharmaceuticals based on silver (I) and silver (II) polydiguanide complexes: activity against burn wound pathogens. J. Antimicrob. Chemother. 65, 2134\u20132140, https:\/\/doi.org\/10.1093\/jac\/dkq294 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"42049_CR9","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1039\/C4NJ00160E","volume":"38","author":"S Pal","year":"2014","unstructured":"Pal, S., Tak, Y. K., Han, E., Rangasamy, S. & Song, J. M. A multifunctional composite of an antibacterial higher-valent silver metallopharmaceutical and a potent wound healing polypeptide: a combined killing and healing approach to wound care. New J. Chem. 38, 3889\u20133898, https:\/\/doi.org\/10.1039\/C4NJ00160E (2014).","journal-title":"New J. Chem."},{"key":"42049_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.burns.2012.06.013","volume":"38","author":"C Rigo","year":"2012","unstructured":"Rigo, C. et al. Characterization and evaluation of silver release from four different dressings used in burns care. Burns. 38, 1131\u20131142, https:\/\/doi.org\/10.1016\/j.burns.2012.06.013 (2012).","journal-title":"Burns."},{"key":"42049_CR11","doi-asserted-by":"publisher","first-page":"15042","DOI":"10.1021\/ja075889z","volume":"129","author":"S Ray","year":"2007","unstructured":"Ray, S. et al. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes. JACS. 129, 15042\u201315053, https:\/\/doi.org\/10.1021\/ja075889z (2007).","journal-title":"JACS."},{"key":"42049_CR12","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos, K. D. & Orvig, C. Metallodrugs in medicinal inorganic chemistry. Chem. Rev. 114, 4540\u20134563, https:\/\/doi.org\/10.1021\/cr400460s (2014).","journal-title":"Chem. Rev."},{"issue":"1","key":"42049_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.poly.2012.03.016","volume":"38","author":"GA Pereira","year":"2012","unstructured":"Pereira, G. A. et al. A broad study of two new promising antimycobacterial drugs: Ag(I) and Au(I) complexes with 2-(2-thienyl)benzothiazole. Polyhedron. 38(1), 291\u2013296, https:\/\/doi.org\/10.1016\/j.poly.2012.03.016 (2012).","journal-title":"Polyhedron."},{"issue":"4","key":"42049_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1155\/2015\/153015","volume":"8","author":"M Mandewale.","year":"2015","unstructured":"Mandewale., M., Thorat, B., Shelke, D. & Yamgar, R. Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu(II) and Zn(II) complexes against Mycobacterium tuberculosis. Bioinorg. Chem. Appl. 8(4), 112\u2013128, https:\/\/doi.org\/10.1155\/2015\/153015 (2015).","journal-title":"Bioinorg. Chem. Appl."},{"key":"42049_CR15","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1128\/AAC.00692-15","volume":"59","author":"AG Dalecki","year":"2015","unstructured":"Dalecki, A. G. et al. Disulfiram and copper ions kill Mycobacterium tuberculosis in a synergistic manner. Antimicrob. Agents Chemother. 59, 4835\u20134844, https:\/\/doi.org\/10.1128\/AAC.00692-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"42049_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.micpath.2017.07.010","volume":"110","author":"A Jafari","year":"2017","unstructured":"Jafari, A., Mosavari, N., Movahedzadeh, F. & Jafari, N. S. Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on H37Rv Mycobacterium tuberculosis phagocytized by THP\u20101 cell lines. Microb. Pathog. 110, 335\u2013344, https:\/\/doi.org\/10.1016\/j.micpath.2017.07.010 (2017).","journal-title":"Microb. Pathog."},{"key":"42049_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","volume":"87","author":"S Ahmad","year":"2007","unstructured":"Ahmad, S., Jaber, A. A. & Mokaddas, E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis. 87, 123\u2013129, https:\/\/doi.org\/10.1016\/j.tube.2006.05.004 (2007).","journal-title":"Tuberculosis."},{"key":"42049_CR18","unstructured":"Bernardelli, A. Manual de Procedimientos. Clasificaci\u00f3n fenot\u00edpica de las micobacterias. Direcci\u00f3n de Laboratorio y Control T\u00e9cnico. Available on:http:\/\/www.senasa.gov.ar\/Archivos\/File\/File1443- mlab.pdf-BioSource (2007)."},{"key":"42049_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/AAC.41.5.1073","volume":"41","author":"S Bajaksouzian","year":"1997","unstructured":"Bajaksouzian, S., Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41, 1073\u20131076 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"42049_CR20","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.47.6.1902-1906.2003","volume":"47","author":"MT Sweeney","year":"2003","unstructured":"Sweeney, M. T. & Zurenko, G. E. In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms. Antimicrob. Agents Chemother. 47(6), 1902\u20131906, https:\/\/doi.org\/10.1128\/AAC.47.6.1902-1906.2003 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"42049_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan, G., Bayram, A., Zer, Y. & Balci, I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J. Clin. Microbiol. 43, 140\u2013143, https:\/\/doi.org\/10.1128\/JCM.43.1.140-143.2005 (2005).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"42049_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/0037-8682-0012-2013","volume":"46","author":"DA Santos","year":"2013","unstructured":"Santos, D. A., Nascimento, M. M., Vitali, L. H. & Martinez, R. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa. Rev. Soc. Bras. Med. Trop. 46(3), 299\u2013303, https:\/\/doi.org\/10.1590\/0037-8682-0012-2013 (2013).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"2","key":"42049_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum, M. C. A method for testing the synergy with any number of agents. J. Infect. Dis. 137(2), 122\u2013130 (1978).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"42049_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0891-5520(20)30277-4","volume":"3","author":"GM Eliopoulos","year":"1989","unstructured":"Eliopoulos, G. M. Synergism and antagonism. Infect. Dis. Clin. North Am. 3(3), 399\u2013406 (1989).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"42049_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.poly.2018.05.062","volume":"152","author":"C Sen","year":"2018","unstructured":"Sen, C. et al. Platinum (II)-azoimidazole drugs against TB and cancer: structural studies, cytotoxicity and anti-mycobacterial activity. Polyhedron. 152, 1\u201310, https:\/\/doi.org\/10.1016\/j.poly.2018.05.062 (2018).","journal-title":"Polyhedron."},{"issue":"6","key":"42049_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep24184","volume":"26","author":"R Pati","year":"2016","unstructured":"Pati, R., Sahu, R., Panda, J. & Sonawane, A. Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages. Sci. Rep. 26(6), 24184, https:\/\/doi.org\/10.1038\/srep24184 (2016).","journal-title":"Sci. Rep."},{"issue":"2","key":"42049_CR27","first-page":"171","volume":"4","author":"SD Patil","year":"2013","unstructured":"Patil, S. D. et al. Synthesis and antimycobacterial activity of Cu (II) complexes containing thiosemicarbazones ligand. Der. Pharmacia Sinica. 4(2), 171\u2013175 (2013).","journal-title":"Der. Pharmacia Sinica."},{"issue":"3","key":"42049_CR28","first-page":"198","volume":"57","author":"M Poggi","year":"2013","unstructured":"Poggi, M. et al. New isoniazid complexes, promising agents against Mycobacterium tuberculosis. J Mex Chem Soc. 57(3), 198\u2013204 (2013).","journal-title":"J Mex Chem Soc."},{"issue":"1","key":"42049_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-9-373","volume":"9","author":"S Gurunathan","year":"2014","unstructured":"Gurunathan, S., Han, J. W., Kwon, D. N. & Kim, J. H. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 9(1), 373, https:\/\/doi.org\/10.1186\/1556-276X-9-373 (2014).","journal-title":"Nanoscale Res. Lett."},{"issue":"6387","key":"42049_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/358591a0","volume":"358","author":"Y Zhang","year":"1992","unstructured":"Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 358(6387), 591\u2013593, https:\/\/doi.org\/10.1038\/358591a0 (1992).","journal-title":"Nature."},{"issue":"24","key":"42049_CR31","doi-asserted-by":"publisher","first-page":"13881","DOI":"10.1073\/pnas.2235848100","volume":"100","author":"R Rawat","year":"2003","unstructured":"Rawat, R., Whitty, A. & Tonge, P. J. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance. Proc. Natl. Acad. Sci. USA 100(24), 13881\u201313886, https:\/\/doi.org\/10.1073\/pnas.2235848100 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42049_CR32","unstructured":"World Health Organization. Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis. WHO\/CDS\/TB\/2018.5."},{"issue":"8","key":"42049_CR33","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino, J. C. et al. Resazurin microtiter assay plate: simple and inexpensive methods for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46(8), 2720\u20132722 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"42049_CR34","doi-asserted-by":"crossref","unstructured":"Freshney, R. I. Culture of Animal Cells. A manual of basic technique (ed. Wiley and Son) (New York 2005).","DOI":"10.1002\/0471747599.cac006"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42049-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42049-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42049-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:27:08Z","timestamp":1671265628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42049-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42049-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"13 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5471"}}